Feasibility of Outpatient Chemotherapy with S-1 and Cisplatin for Gastric Cancer

• 作者: Akihito Tsuji Hironaga Satake Mikio Fujita Takeshi Kotake
• 来源期刊: 癌症治疗(英文)
• 学科: 医学
• 关键词: Gastric Cancer CISPLATIN S-1 Short HYDRATION OUTPATIENT Chemotherapy
• 年，卷（期）: azzlyw_2014,（8）
• 页码范围: 759-765
• 页数: 7页
• 分类号: R73

摘要

Objective: To evaluate the feasibility of S-1 and high-dose cisplatin short hydration regimens for outpatients with unresectable metastatic gastric cancer. Methods: Data for individual outpatients treated in our institution were retrospectively pooled to assess the feasibility of an S-1 and highdose cisplatin short hydration regimen (S-1: 80 to 120 mg on Days 1 to 21;cisplatin: 60 mg/m2?on Day 8, every 5 weeks), which included 2250 ml of intravenous fluids and 1000 ml oral hydration. Ten consecutive patients were treated with S-1 and high-dose cisplatin short hydration for unresectable metastatic gastric cancer from July 2011 to May 2012 and were included in the analysis. Results: With a median of 3.5 medication cycles, unscheduled admission occurred in two patients for 5 days each due to paralytic ileus and cerebral infarction. Four patients required dose reduction, in both S-1 and cisplatin in two patients, and in S-1 alone and cisplatin alone in one patient each. Renal function transiently declined after administration of cisplatin, but serum creatinine level and estimated glomerular filtration rate were both improved by the time of the next administration. Conclusion: This study suggests that an S-1 and high-dose cisplatin short hydration strategy for outpatients with unresectable metastatic gastric cancer might be feasible.